Myeloma Clinical Trials
The following is a listing of myeloma clinical trials associated with this tag.
All Clinical Trials
View all active clinical trials around the US.
Verified
SparkCures Verified Accurate, up-to-date information. Learn more
A Master Protocol for Biomarker-Based Treatment of AML (The Beat AML Trial)
THE BEAT AML TRIALA Phase 1 Study of Adding Venetoclax to a Reduced Intensity Conditioning Regimen and to Maintenance in Comb...
VENETOCLAX IN PRE- AND POST-TRANSPLANT THERAPYA Phase 2 Study of Fludarabine, Cytarabine, Filgrastim-sndz,Gemtuzumab Ozogamicin and Idarubicin in Newly D...
GEMTUZUMAB AS PART OF CHEMOTHERAPYA Phase 2 Trial Investigating Decitabine in Combination With a JAK-Inhibitor as a Bridge to Allogeneic Hema...
DECITABINE PLUS A JAK-INHIBITORA Phase I/II Study of Azacitidine, Venetoclax, and Gilteritinib for Patients With Acute Myeloid Leukemia or...
AZACITIDINE, VENETOCLAX, AND GILTERITINIBA Phase I/II Study of Quizartinib in Combination With Decitabine and Venetoclax for the Treatment of Patien...
QUIZARTINIB WITH DECITABINE AND VENETOCLAXA Phase Ib Study of Oral Decitabine/Cedazuridine as Maintenance Therapy Following Allogeneic Hematopoietic ...
DECITABINE/CEDAZURIDINE AS MAINTENANCE THERAPYA Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Aza...
CLADRIBINE, CYTARABINE AND VENETOCLAX FOR HR-MDSMetabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
LOW DOSE WEEKLY DECITABINE/VENETOCLAXPhase 1b Study of Pembrolizumab, Decitabine +/- Venetoclax Combination Therapy in Patients With Relapsed or...
PEMBROLIZUMAB, DECITABINE +/- VENETOCLAXPhase I/II of Venetoclax in Combination With Azacitidine in Treatment Naïve and Relapse Refractory High Ris...
VENETOCLAX PLUS AZACITIDINEPhase I/II Study of Azacitidine in Combination With Quizartinib for Patients With Myelodysplastic Syndromes...
AZACITIDINE PLUS QUIZARTINIBPhase II Study of Cladribine Plus Low Dose Cytarabine (LDAC) Induction Followed By Consolidation With Cladr...
CYTARABINE ALTERNATING WITH DECITABINEPhase II Study of Clinical Efficacy of Venetoclax in Combination With Azacitidine in Patients With Therapy ...
VENETOCLAX AND AZACITIDINE FOR THERAPY-RELATED MDSVenetoclax in Combination With ASTX727, an All-Oral Therapy for Chronic Myelomonocytic Leukemia and Other M...
VENETOCLAX IN COMBINATION WITH ASTX727
Multiple Myeloma
No active clinical trials
Smoldering Myeloma
No active clinical trials
Monoclonal Gammopathy of Undetermined Significance (MGUS)
No active clinical trials